Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)
Open Access

Spatial normalization of [18F]flutemetamol PET images utilizing an adaptive principal components template

Johan Lilja, Antoine Leuzy, Konstantinos Chiotis, Irina Savitcheva, Jens Sörensen and Agneta Nordberg
Journal of Nuclear Medicine June 2018, jnumed.118.207811; DOI: https://doi.org/10.2967/jnumed.118.207811
Johan Lilja
1 Uppsala University, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Leuzy
2 Karolinska Institutet, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos Chiotis
2 Karolinska Institutet, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irina Savitcheva
3 Karolinska University Hospital Huddinge, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Sörensen
1 Uppsala University, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agneta Nordberg
2 Karolinska Institutet, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Abstract

Though currently approved for visual assessment only, there is evidence to suggest that quantification of amyloid-β (Aβ) PET images may reduce inter-reader variability and aid in the monitoring of treatment effects in clinical trials. Quantification typically involves a regional atlas in standard space, requiring PET images to be spatially normalized. Different uptake patterns in Aβ-positive and Aβ-negative subjects, however, makes spatial normalization challenging. In this study we propose a method to spatially normalize [18F]flutemetamol images, using a synthetic template based on principal component images to overcome these challenges. Methods: [18F]Flutemetamol PET and corresponding MR images from a phase II trial (n = 70), including subjects ranging from Aβ-negative to Aβ-positive, were spatially normalized to standard space using an MR driven registration method (SPM12). [18F]Flutemetamol images were then intensity normalized using the pons as reference region. Principal component images were calculated from the intensity normalized images. A linear combination of the first two principal component images was then used to model a synthetic template, spanning the whole range from Aβ-negative to Aβ-positive. The synthetic template was then incorporated in our registration method, where the optimal template was calculated as part of the registration process, providing a PET only driven registration method. Evaluation of the method was done in two steps. First, co-registered gray matter masks generated using SPM12 were spatially normalized using the PET and MR driven methods, respectively. The spatially normalized gray matter masks were then visually inspected and quantified. Secondly, to quantitatively compare the two registration methods, additional data from an ongoing study were spatially normalized using both methods with correlation analysis on the resulting cortical SUVR values. Results: All scans were successfully spatially normalized using the proposed method, with no manual adjustments performed. Both visual and quantitative comparison between the PET and MR driven methods showed high agreement in cortical regions. [18F]Flutemetamol quantification showed strong agreement between the SUVR values for the PET and MR driven methods (R2=0.996; pons reference region). Conclusion: The principal component template registration method allows for robust and accurate registration of [18F]flutemetamol images to a standardized template space, without the need for an MR image.

  • Molecular Imaging
  • Neurology
  • PET
  • Alzheimer’s disease
  • PET
  • [18F]flutemetamol
  • adaptive template
  • amyloid-β

Footnotes

  • Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

  • Copyright © 2018 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (3)
Journal of Nuclear Medicine
Vol. 64, Issue 3
March 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Spatial normalization of [18F]flutemetamol PET images utilizing an adaptive principal components template
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Spatial normalization of [18F]flutemetamol PET images utilizing an adaptive principal components template
Johan Lilja, Antoine Leuzy, Konstantinos Chiotis, Irina Savitcheva, Jens Sörensen, Agneta Nordberg
Journal of Nuclear Medicine Jun 2018, jnumed.118.207811; DOI: 10.2967/jnumed.118.207811

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Spatial normalization of [18F]flutemetamol PET images utilizing an adaptive principal components template
Johan Lilja, Antoine Leuzy, Konstantinos Chiotis, Irina Savitcheva, Jens Sörensen, Agneta Nordberg
Journal of Nuclear Medicine Jun 2018, jnumed.118.207811; DOI: 10.2967/jnumed.118.207811
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Derivation and utility of an A{beta}-PET pathology accumulation index to estimate A{beta} load
  • A{beta}-PET pathology accumulation index: Ready for the clinic?
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • Radioimmunoscintigraphy and pre-treatment dosimetry of 131I-omburtamab for planning treatment of leptomeningeal disease
  • PSMA PET/CT–based Atlas for Prostatic Bed Recurrence after Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines
  • PSMA-GCK01 - A Generator-Based 99mTc-/188Re-Theranostic Ligand for the Prostate-Specific Membrane Antigen
Show more Clinical Investigations (Human)

Clinical (Neurology)

  • Tau PET Visual Reads: Research and Clinical Applications and Future Directions
  • Diagnostic utility of amino acid PET in the differential diagnosis of recurrent brain metastases and treatment-related changes: a meta-analysis
  • Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
Show more Clinical (Neurology)

Similar Articles

Keywords

  • molecular imaging
  • neurology
  • PET
  • Alzheimer’s disease
  • [18F]flutemetamol
  • adaptive template
  • Amyloid-β
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire